[1]
Sadikova N.G, Najmutdinova D. K, Urunbayeva D. A, Alimova S. E and Tillaboyev Sh.Sh 2023. Sglt-2 Inhibitors in Diabetic Type 2 Patients Nephroprotective Effects of (Empagliflozin). Genius Repository. 26, (Nov. 2023), 1–4.